Contact

AMA Issues CPT® Category III Codes for Mechanical Scalp Cooling

AMA issues CPT® Category III codes for Mechanical Scalp Cooling, further facilitating the treatment of chemotherapy-induced hair loss

PAXMAN AB today announces that the American Medical Association (AMA) has issued two (2) separate CPT® codes for the "mechanical scalp cooling". The CPT® Category III codes are: 0662T and 0663T and are effective July 1, 2020.

The two new category lll codes for the Paxman Scalp cooling procedure are:

  1. Scalp cooling, mechanical; initial measurement and calibration of cap. (Report 0662T once per chemotherapy treatment period)
  2. Placement of device, monitoring, and removal of device (List separately in addition to code for primary procedure)

(Use 0663T in conjunction with 96409, 96411, 96413, 96415, 96416, 96417)
(Report 0663T once per chemotherapy session)

The issuance of two Category III CPT Codes by the AMA is a key component to PAXMAN's reimbursement and business strategies. Richard Paxman, CEO of PAXMAN, stated, "As we strive to expand patient access to the Paxman Scalp Cooler, the new CPT codes for mechanical scalp cooling have been a priority for our organization. These CPT codes, combined with the extensive work PAXMAN is doing in the area of reimbursement, will expand patient access and enable oncology facilities to appropriately provide this solution to their patients who would otherwise potentially suffer from the devastating side effect of chemotherapy-induced hair loss. This is, a business catalyst for the company and an important access strategy for the patients we serve."

PAXMAN, the leading global manufacturer and supplier of scalp cooling equipment, offers scalp cooling technology to over 350 of the top community and academic oncology centers the United States.

For a full list of the codes please visit CPT® Category III Codes Long Descriptors (PDF, updated Dec. 30, 2020)

AMA Issues CPT® Category III Codes for Mechanical Scalp Cooling AMA Issues CPT® Category III Codes for Mechanical Scalp Cooling
What we do
Paxman are world leaders in chemotherapy side effect management on an ambitious journey to change the face of cancer through cryotherapy-based treatments. The Paxman mission is to democratise access to scalp cooling globally.
Learn more →
Financial Information
Read the latest Paxman financial reports. In these comprehensive documents, you will find a detailed overview of our financial performance, key milestones, and a strategic outlook for the future. Reports are published quarterly and annually.
Read reports  →
Investing in Paxman
Paxman has treated 100,000+ patients and installed 5,000+ systems in more than 65 countries worldwide. We are helping to manage the trauma of chemotherapy hair loss. By investing in Paxman, you're not just supporting a company; you're joining us in changing the face of cancer.
Visit the Investor Centre →
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram